AMARIN CORP PLC\UK Earnings Per Share, Basic and Diluted
AMARIN CORP PLC\UK (AMRN) reported Earnings Per Share, Basic and Diluted of -$0.08 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- AMARIN CORP PLC\UK earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.08.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.03.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.00.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.02.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for fiscal 2020 was -$0.05.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for fiscal 2019 was -$0.07.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for fiscal 2018 was -$0.39.
- AMARIN CORP PLC\UK earnings per share, basic and diluted for fiscal 2017 was -$0.25.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.08 10-Q · filed 2022-05-04 | |||||
| 2021-09-30 | -$0.03 10-Q · filed 2021-11-03 | -$0.02 10-Q · filed 2021-11-03 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||||
| 2020-12-31 | -$0.05 10-K · filed 2021-02-25 | |||||
| 2020-09-30 | -$0.02 10-Q · filed 2021-11-03 | -$0.06 10-Q · filed 2021-11-03 | ||||
| 2020-03-31 | -$0.06 10-Q · filed 2021-04-29 | |||||
| 2019-12-31 | -$0.07 10-K · filed 2021-02-25 | |||||
| 2019-09-30 | -$0.01 10-Q · filed 2020-11-05 | -$0.09 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | -$0.01 10-Q · filed 2019-07-31 | -$0.08 10-Q · filed 2019-07-31 | ||||
| 2019-03-31 | -$0.07 10-Q · filed 2020-04-30 | |||||
| 2018-12-31 | -$0.39 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | -$0.08 10-Q · filed 2019-11-05 | -$0.28 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | -$0.12 10-Q · filed 2019-07-31 | -$0.20 10-Q · filed 2019-07-31 | ||||
| 2018-03-31 | -$0.08 10-Q · filed 2019-05-01 | |||||
| 2017-12-31 | -$0.25 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | -$0.04 10-Q · filed 2018-11-01 | -$0.17 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | -$0.05 10-Q · filed 2018-08-01 | -$0.13 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | -$0.08 10-Q · filed 2018-05-02 | |||||
| 2016-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$0.18 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$0.26 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$0.41 10-K · filed 2019-02-27 | ||
| 2016-09-30 | -$0.08 10-Q · filed 2017-11-01 | -$0.15 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$0.31 10-Q · filed 2017-11-01 | -$0.42 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||
| 2016-06-30 | -$0.07 10-Q · filed 2017-08-02 | -$0.23 10-Q · filed 2017-08-02 | -$0.35 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.53 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||
| 2016-03-31 | -$0.16 10-Q · filed 2017-05-03 | -$0.28 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.80 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||
| 2015-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.30 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.64 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$0.83 10-K · filed 2018-02-27 | ||
| 2015-09-30 | -$0.18 10-Q · filed 2016-11-03 | -$0.52 derived: net income ÷ weighted average shares · filed 2016-11-03 | -$0.71 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | -$0.35 10-Q · filed 2016-08-04 | -$0.53 10-Q · filed 2016-08-04 | ||||
| 2013-09-30 | -$0.29 10-Q · filed 2013-11-07 | -$0.96 10-Q · filed 2013-11-07 | ||||
| 2013-06-30 | -$0.26 10-Q · filed 2013-08-08 | -$0.68 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | -$0.41 10-Q · filed 2013-05-09 | |||||
| 2012-12-31 | -$1.24 10-K · filed 2013-02-28 | |||||
| 2012-09-30 | -$0.18 10-Q · filed 2013-11-07 | -$1.19 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | -$0.38 10-Q · filed 2013-08-08 | $0.38 10-Q · filed 2012-08-08 | -$1.03 10-Q · filed 2013-08-08 | $1.03 10-Q · filed 2012-08-08 | ||
| 2012-03-31 | -$0.65 10-Q · filed 2013-05-09 | |||||
| 2011-12-31 | -$0.53 10-K · filed 2013-02-28 | |||||
| 2011-06-30 | $1.58 10-Q · filed 2012-08-08 | $1.46 10-Q · filed 2012-08-08 | ||||
| 2010-12-31 | -$1.82 10-K · filed 2012-02-29 | -$2.49 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$0.11 10-K · filed 2012-02-29 | |||||
| 2010-06-30 | -$0.42 10-K · filed 2012-02-29 | $0.42 10-Q · filed 2011-08-09 | $0.51 10-Q · filed 2011-08-09 | |||
| 2010-03-31 | -$0.09 10-K · filed 2012-02-29 | |||||
| 2009-12-31 | -$0.72 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |